Ge­netic sleep dis­or­der med­i­ca­tion gets FDA OK

Baltimore Sun - - AROUND THE REGION -

Lupin Phar­ma­ceu­ti­cals Inc., the Bal­ti­more-based sub­sidiary of In­dian drug maker Lupin Ltd., has re­ceived fi­nal reg­u­la­tory ap­proval for a generic sleep dis­or­der med­i­ca­tion. Lupin’s Ar­modafini is a generic ver­sion of Cephalon Inc.’s Nu­vigil, used to treat nar­colepsy, sleep ap­nea and shift work dis­or­der among adults. The tablet comes in doses rang­ing from 50 mg to 250 mg. The fi­nal reg­u­la­tory ap­proval from

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.